Aligos Therapeutics

ALGS68

High Growth

$20.04arrow_drop_up0.65%$0.13

High Growth

ALGS68

$20.04

arrow_drop_up0.65%$0.13

High Growth

Performance History

Key Stats
Open	$20.01
Prev. Close	$19.79
EPS	-7.25
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$71.90M
PE Ratio	-

	LOW	HIGH
Day Range	18.85	20.62
52 Week Range	7.35	30.00

Ratios







EPS	-7.25

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Aligos Therapeutics (ALGS)

Aligos Therapeutics Inc (ALGS) is a biopharmaceutical company that is focused on the development of targeted therapeutics for the treatment of viral infections and liver diseases. The company's mission is to improve the lives of patients suffering from these devastating diseases by developing innovative therapies that target the underlying cause of the disease. ALGS is dedicated to advancing the field of antiviral therapeutics and liver disease research through its proprietary platform technologies and strategic partnerships.

The stock price history of ALGS shows that it has experienced volatility over the years, with fluctuations in response to market conditions, industry trends, and company-specific factors. Investors should carefully assess these factors and consider their risk tolerance before investing in ALGS. As of the latest available data, the stock price of ALGS is $X.XX per share.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Lawrence M. Blatt MBA, Ph.D.
Headquarters: South San Francisco
Employees: 68
Exchange: NASDAQ

Keep an eye on Aligos Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Aligos Therapeutics 's (ALGS) price per share?

The current price per share for Aligos Therapeutics (ALGS) is $20.04. The stock has seen a price change of $0.13 recently, indicating a 0.66% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Aligos Therapeutics (ALGS)?

For Aligos Therapeutics (ALGS), the 52-week high is $30, which is 49.7% from the current price. The 52-week low is $7.35, the current price is 172.65% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Aligos Therapeutics (ALGS) a growth stock?

Aligos Therapeutics (ALGS) has shown an average price growth of -4.13% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aligos Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Aligos Therapeutics (ALGS) stock price performance year to date (YTD)?

As of the latest data, Aligos Therapeutics (ALGS) has a year-to-date price change of 13%. Over the past month, the stock has experienced a price change of 173.02%. Over the last three months, the change has been 44.8%. Over the past six months, the figure is 21.64%.

help

Is Aligos Therapeutics (ALGS) a profitable company?

Aligos Therapeutics (ALGS) has a net income of -$87.68M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 80.24% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -1.59K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $15.53M, with a revenue growth rate of 11.66%, providing insight into the company's sales performance and growth. The gross profit is $12.46M. Operating income is noted at -$87.43M. Furthermore, the EBITDA is -$92.68M.

help

What is the market capitalization of Aligos Therapeutics (ALGS)?

Aligos Therapeutics (ALGS) has a market capitalization of $71.9M. The average daily trading volume is 19.78, indicating the stock's liquidity and investor engagement.